Compare Cytokinetics Inc (CYTK) vs KraneShares CSI China Internet ETF (KWEB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs KraneShares CSI China Internet ETF — how do they compare? Cytokinetics Inc trades at $62.2 (market cap $8.62B), while KraneShares CSI China Internet ETF trades at $24.82 (market cap $4.37B). The key difference: Cytokinetics Inc is the larger of the two by market cap, and Cytokinetics Inc is trading nearer its 52-week high, KraneShares CSI China Internet ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cytokinetics Inc for 19 Days and KraneShares CSI China Internet ETF for 57 Days on average.
| CYTK | KWEB | |
|---|---|---|
Market Cap | $8.62B | $4.37B |
Volume | 2,594,626 | 13,393,361 |
Sector | Health | Sector/Thematic |
52-Week High | $87.26 | $41.35 |
52-Week Low | $54.76 | $23.63 |
Typical Hold Time | 19 Days | 57 Days |
Enterprise Value | $8.72B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cytokinetics (CYTK) trades at $62.48, up 2.23% today, but faces bearish technical signals with 18 sell indicators versus 4 buy signals. The company shows strong revenue growth potential with recent positive Phase 3 trial results for aficamten in non-obstructive HCM, though it operates at significant losses with a -1,321% net income margin. Cash flow remains heavily dependent on financing activities, with operating cash flow negative at -$555 million in 2026.
Wall Street maintains strong bullish sentiment with 97% buy ratings and a $112.60 consensus price target, representing 80% upside potential. Key risks include continued cash burn, competitive pressure from Bristol Myers Squibb's Camzyos, and the need for successful commercialization of pipeline drugs. The stock's valuation appears stretched at 114x sales given current financial performance.
KWEB trades at $24.87, up 2.22% with bearish technical signals from moving averages and neutral oscillators. Recent news highlights institutional position changes and China-focused economic developments. The ETF faces headwinds from U.S.-China trade dynamics and Chinese industrial overcapacity concerns.
The outlook remains cautious due to geopolitical risks and technical weakness. Investment opportunities exist for those bullish on China's internet sector recovery, but risks include trade tensions and economic rebalancing pressures that could impact performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About KraneShares CSI China Internet ETF
KWEB tracks the CSI Overseas China Internet Index, providing exposure to Chinese software and services companies listed in the US and Hong Kong, including giants like Tencent, Alibaba, and Meituan.
Read more on KWEB →
